BridgeMD
Compares treatment options for Prostate Cancer Patients Undergoing Radical Prostatectomy
Official title Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer
ClinicalTrials.gov ID: NCT07308990
What this study is testing
- What it's testing
- This is a randomized controlled study assessing outcome of low (no or limited) versus high (limited or extended) extent of lymph node dissection in addition to radical prostatectomy in patients with operable localized or locally advanced prostate cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Age over 18 years.
- Histologically confirmed localized or locally advanced prostate cancer (adenocarcinoma without a neuroendocrine component).
- No evidence of metastatic spread of the tumor
- Local resectability of the tumor according to digital rectal examination and/or CT and/or MRI of the pelvis
- Patients are suitable for radical prostatectomy based on their comorbidities and life expectancy.
You likely can't join if
- Presence of another active malignant invasive neoplasm.
- Contraindication to pelvic lymph node dissection (e.g., history of radiation therapy to the pelvis).
- The evidence of metastases in regional lymph nodes according to preoperative examination data (including PET/CT with PSMA).
- Severe concomitant disease limiting participation in the study.
See the full eligibility criteria
- Age over 18 years.
- Histologically confirmed localized or locally advanced prostate cancer (adenocarcinoma without a neuroendocrine component).
- No evidence of metastatic spread of the tumor
- Local resectability of the tumor according to digital rectal examination and/or CT and/or MRI of the pelvis
- Patients are suitable for radical prostatectomy based on their comorbidities and life expectancy.
- Signed informed consent to participate in the study.
- Presence of another active malignant invasive neoplasm.
- Contraindication to pelvic lymph node dissection (e.g., history of radiation therapy to the pelvis).
- The evidence of metastases in regional lymph nodes according to preoperative examination data (including PET/CT with PSMA).
- Severe concomitant disease limiting participation in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Lyasny, Minsk Oblast, Belarus
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyasny, Minsk Oblast, Belarus. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.